# Metagenomi Therapeutics, Inc.: Form DEF 14A, filed Apr 27, 2026

- Company: [Metagenomi Therapeutics, Inc.](/companies/mgx.md) (CIK 1785279)
- Form: DEF 14A
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 16:55 ET
- Period: 2026-04-21
- Accession: 0001193125-26-182325
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1785279/000119312526182325/mgx-20260421.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1785279/000119312526182325/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1785279/000119312526182325/mgx-20260421.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-182325. Last ingested by Listed: Nov 11, 2026, 00:33 ET. No prices; not investment advice.
